Melissa Yellson

DNP Doctor of Nursing Practice,  Charité - Universitätsmedizin Berlin 

Location: Germany

Consulting Services

Career Advice and Mentoring Data Science-Bioinformatics Pharma-CRO-Device

Areas Of Interest

Delirium, Subacute Diversion, Ambulance Cutaneous Surgery Ventricular Tachycardias, Slow L-myc Proto-Oncogene Xray Film Mouse, Inbred DBA Rubus fruticosus Anti-Asthmatic Agents Phosphotransferases Combined Immunodeficiency, X-Linked Prostaglandins A, Synthetic v-sis Oncogene Zapotes Inflammatory Polyneuropathy Acute Colocynth Head Movement Bromochlorofluorocarbons Hypercalcemic Hormone of Malignancy Necrovirus Sulfate Anhydrous, Atropine Chiari-Frommel Syndrome Crush Fracture Assay, Clonogenic Cell Ioxaglate, Methylglucamine Norpregnenes Metallic Taste Post-Procedural Delayed Awakenings ARNTL2 Protein Painful Diabetic Neuropathy Bypass, Jejunoileal

Professional Narrative

Dr. Melissa Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Senior Director, Harvard Med 1996
Medical Writer, Mayo Clinic 1987

Education

Doctor of medicine, Weill Medical College 2013
Master of Science in physician assistant, Weill Medical College 2006

Referees

Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02